Skip to main content
Fig. 2 | Journal of Hematology & Oncology

Fig. 2

From: Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party

Fig. 2

Transplant outcomes according to the use of ATG. Cumulative incidence of non-relapse mortality (NRM) (a), of relapse (b), leukemia-free survival (c), and overall survival (d) in the ATG and no-ATG groups as mentioned

Back to article page